Ubie is a Japanese health technology platform founded in 2017.
The company was created by engineer Kota Kubo doctor Abe.
Its mission is guiding people toward medical care using technology.
Ubie originated as a graduate project at University of Tokyo.
The startup expanded into the United States during 2022 period.
Growth was driven by its artificial intelligence Symptom Checker tool.
The system analyses symptoms before suggesting possible conditions and guidance.
Its database includes more than fifty thousand reviewed medical papers.
Probability modelling links symptoms with diseases to improve diagnostic accuracy.
Ubie Smart Support automates patient intake replacing traditional call centres.
The service uses anonymised data provided through the Mayo Clinic.
It can triage cases and advise patients to seek help.
Another division Ubie for Pharma partners with global pharmaceutical companies.
The programme helps identify rare disease patients and direct care.
Ubie accessed data from ten million patients through Mayo programmes.
This significantly improved accuracy especially for respiratory and neurological conditions.
Today Ubie supports more than eighteen hundred medical institutions nationwide.
Approximately ninety percent of leading global pharmaceutical companies use services.
Kubo emphasised artificial intelligence should support doctors rather than replace.
We don’t want AI to replace humans parts.
Kubo said.
The platform prioritises empathy and warmth by incorporating user feedback.
Human oversight remains central ensuring technology enhances accessibility not exclusion.
From Japan the company now operates across international healthcare markets.
Executives say balanced innovation can make quality healthcare universally accessible.
Ubie aims to simplify healthcare delivery making support faster worldwide.